Related Experiment Video
Updated: Feb 16, 2026

09:04
Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Published on: September 25, 2019
8.8K
CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
Zhao Zhang1, Yuelin Zhang1, Fei Gao1
1Department of Medicine, University of Hong Kong, Hong Kong, China.
Molecular Therapy. Nucleic Acids
|December 17, 2017
Summary
The CRISPR/Cas9 system offers efficient and cost-effective genome editing for human stem cells, overcoming limitations of older methods. Further research is needed to address challenges for regenerative medicine applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- Traditional genome editing methods for human stem cells suffer from low efficiency, high costs, and poor specificity.
- The CRISPR/Cas9 system presents a novel, efficient, and cost-effective alternative for gene manipulation.
Purpose of the Study:
- To review the fundamental biology and applications of the CRISPR/Cas9 system in human stem cell research.
- To discuss the advantages and challenges associated with CRISPR/Cas9 technology in this context.
- To explore future prospects of CRISPR/Cas9 in regenerative medicine.
Main Methods:
- Review of current literature on CRISPR/Cas9 technology and its application in human stem cells.
- Analysis of the advantages and limitations of the CRISPR/Cas9 system.
- Discussion of potential future directions and challenges.
Main Results:
- CRISPR/Cas9 demonstrates high editing efficiency and lower costs compared to traditional nucleases.
- Significant potential exists for CRISPR/Cas9 in manipulating genes across various organisms, including human stem cells.
- Challenges remain in optimizing CRISPR/Cas9 for safe and effective human stem cell applications.
Conclusions:
- CRISPR/Cas9 is a powerful tool for human stem cell research with significant potential for regenerative medicine.
- Addressing current challenges is crucial for realizing the full therapeutic promise of CRISPR/Cas9 in stem cell applications.
- Continued research and development are essential for advancing CRISPR/Cas9-based therapies.
Related Concept Videos
CRISPR/Cas9 Genome Editing
2.0K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.0K
CRISPR
58.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.0K
CRISPR and crRNAs
19.2K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.2K
Homologous Recombination
63.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
63.7K
What is Genetic Engineering?
80.4K
Overview
80.4K

